comparative effectiveness

Same Survival and Toxicity With APBI and WBI for Breast Cancer

05/04/2016

JCP Editors

Accelerated partial breast irradiation (APBI) leads to the same rates of survival and toxicity as whole breast irradiation (WBI) while also producing significantly better cosmetic results, according to phase 3 trial...

...

05/04/2016

Journal of Clinical Pathways

Breast Conserving Therapy Likely to Result in Recurrence

05/03/2016

JCP Editors

Women younger than 45 years who opt for breast conserving therapy (BCT) over mastectomy may have a higher risk of developing a local recurrence over a 20-year period, according to research presented at European...

Women...

05/03/2016

Journal of Clinical Pathways

Radiation Therapy Better for Testicular Cancer Than Chemotherapy

05/02/2016

JCP Editors

Radiation therapy may be superior to chemotherapy for patients with stage 2a-b testicular cancer, according to results presented at European Society for Therapeutic Radiology and Oncology (ESTRO) 35 (April 29-May 3,...

...

05/02/2016

Journal of Clinical Pathways

Research in Review

Radiotherapy Plus Surgery Better for Older Patients With Soft-Tissue Sarcoma

04/29/2016

JCP Editors

Age may be a significant determinant of the effectiveness of radiotherapy in patients with soft-tissue sarcoma undergoing surgery, according to a recent study. While the survival rates for early-stage, soft-tissue...

Age...

04/29/2016

Journal of Clinical Pathways

Nivolumab More than Doubles One-Year Overall Survival in Head/Neck Cancer

04/27/2016

JCP Editors

Treatment with nivolumab reduced the risk of death and improved one-year overall survival (OS) compared with investigator’s choice of therapy for patients with recurrent or metastatic head and neck squamous cell...

...

04/27/2016

Journal of Clinical Pathways

Research in Review

Head-to-Head Trial Compares Outcomes With EGFR+ NSCLC Treatments

04/18/2016

JCP Editors

Early results of a head-to-head trial comparing two prominent treatments for patients with EGFR mutation-positive non-small cell lung cancer (NSCLC) could have a significant impact on clinical decision making for...

Early...

04/18/2016

Journal of Clinical Pathways

Research in Review

Adding Chemotherapy to Radiation Therapy Improves Long-Term Outcomes for Patients With Low-Grade Brain Tumors

04/08/2016

JCP Editors

The combination of chemotherapy and radiation therapy may improve progression-free survival (PFS) and overall survival in patients with grade 2 glioma, according to a recent study. Glioma is a form of brain cancer...

The...

04/08/2016

Journal of Clinical Pathways

NCCN Announces Changes to Guidelines for NSCLC

04/06/2016

JCP Editors

New guidelines for non-small cell lung cancer (NSCLC) recommend testing for epidermal growth factor receptor (EGRF) mutations as a part of routine care for patients diagnosed with non-small cell lung cancer (NSCLC),...

New...

04/06/2016

Journal of Clinical Pathways

Understanding New Treatments for Chronic Lymphocytic Leukemia

04/04/2016

JCP Editors

Recent Food and Drug Administration (FDA) approvals have changed the landscape of treatment for chronic lymphocytic leukemia (CLL). In a session at the 2016 National Comprehensive Cancer Network (NCCN) Annual...

Recent...

04/04/2016

Journal of Clinical Pathways

Research in Review

Atezolizumab Safely Improves Survival for Patients Previously Treated for Non-Small Cell Lung Cancer

04/01/2016

JCP Editors

Atezolizumab may be a safe and effective option for patients with non-small cell lung cancer (NSCLC) who have progressed on post-platinum chemotherapy, according to results from a phase 2 randomized controlled...

...

04/01/2016

Journal of Clinical Pathways